Host-Pathogen Interactions in Urinary Tract Infections

키워드

참고문헌 (67)

1. Stamm WE, "Urinary tract infections: disease panorama and challenges", J Infect Dis, 183(Suppl 1), pp.S1~S4 (2001)
2. Newman JW, "The contribution of Pseudomonas aeruginosa virulence factors and host factors in the establishment of urinary tract infections", FEMS Microbiol Lett, 364, pp.fnx124~ (2017)
3. Hooton TM, "Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults : 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America", Clin Infect Dis, 50, pp.625~663 (2010)
4. Nicolle LE, "Catheter-related urinary tract infection", Drugs Aging, 22, pp.627~639 (2005)
5. Flores-Mireles AL, "Urinary tract infections : epidemiology, mechanisms of infection and treatment options", Nat Rev Microbiol, 13, pp.269~284 (2015)
6. Sosa V, "Proteus mirabilis isolates of different origins do not show correlation with virulence attributes and can colonize the urinary tract of mice", Microbiology, 152, pp.2149~2157 (2006)
7. Lloyd AL, "Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli", J Bacteriol, 189, pp.3532~3546 (2007)
8. Flannery EL, "Identification of a modular pathogenicity island that is widespread among urease-producing uropathogens and shares features with a diverse group of mobile elements", Infect Immun, 77, pp.4887~4894 (2009)
9. Nielubowicz GR, "Host-pathogen interactions in urinary tract infection", Nat Rev Urol, 7, pp.430~441 (2010)
10. Kostakioti M, "Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics", Virulence, 3, pp.592~594 (2012)
11. Subashchandrabose S, "Host-specific induction of Escherichia coli fitness genes during human urinary tract infection", Proc Natl Acad Sci U S A, 111, pp.18327~18332 (2014)
12. Terlizzi ME, "UroPathogenic Escherichia coli(UPEC)infections : virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies", Front Microbiol, 8, pp.1566~ (2017)
13. O’Brien VP, "Drug and vaccine development for the treatment and prevention of urinary tract infections", Microbiol Spectr, 4, pp.1~42 (2016)
14. Aguiniga LM, "Lipopolysaccharide domains modulate urovirulence", Infect Immun, 84, pp.3131~3140 (2016)
15. Zhang G, "On the essentiality of lipopolysaccharide to Gram-negative bacteria", Curr Opin Microbiol, 16, pp.779~785 (2013)
16. Hannan TJ, "Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection", FEMS Microbiol Rev, 36, pp.616~648 (2012)
17. Martinez JJ, "Requirement of Rho-family GTPases in the invasion of type 1-piliated uropathogenic Escherichia coli", Cell Microbiol, 4, pp.19~28 (2002)
18. Schwan WR, "Regulation of fim genes in uropathogenic Escherichia coli", World J Clin Infect Dis, 1, pp.17~25 (2011)
19. Wright KJ, "Sticky fibers and uropathogenesis : bacterial adhesins in the urinary tract", Future Microbiol, 1, pp.75~87 (2006)
20. Rice JC, "Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney", J Am Soc Nephrol, 16, pp.3583~3591 (2005)
21. Barnhart MM, "Curli biogenesis and function", Annu Rev Microbiol, 60, pp.131~147 (2006)
22. Vigil PD, "Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract", MBio, 2, pp.e00066~ (2011)
23. Nesta B, "FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections", MBio, 3, pp.e00010~e00012 (2012)
24. Johnson JR, "The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection", Infect Immun, 73, pp.965~971 (2005)
25. Dhakal BK, "The UPEC pore-forming toxin -hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways", Cell Host Microbe, 11, pp.58~69 (2012)
26. Nagamatsu K, "Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection", Proc Natl Acad Sci U S A, 112, pp.E871~E880 (2015)
27. Garcia TA, "Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder", Infect Immun, 81, pp.99~109 (2013)
28. Guyer DM, "Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells", Infect Immun, 70, pp.4539~4546 (2002)
29. Heimer SR, "Autotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection", Infect Immun, 72, pp.593~597 (2004)
30. Lane MC, "Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract", Proc Natl Acad Sci U S A, 104, pp.16669~16674 (2007)
31. Garcia EC, "Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection", Infect Immun, 79, pp.1225~1235 (2011)
32. Chaturvedi KS, "The siderophore yersiniabactin binds copper to protect pathogens during infection", Nat Chem Biol, 8, pp.731~736 (2012)
33. Hagan EC, "Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection", Mol Microbiol, 71, pp.79~91 (2009)
34. Subashchandrabose S, "Back to the metal age : battle for metals at the host-pathogen interface during urinary tract infection", Metallomics, 7, pp.935~942 (2015)
35. Kehl-Fie TE, "Nutritional immunity beyond iron : a role for manganese and zinc", Curr Opin Chem Biol, 14, pp.218~224 (2010)
36. Sabri M, "Roles of the extraintestinal pathogenic Escherichia coli ZnuACB and ZupT zinc transporters during urinary tract infection", Infect Immun, 77, pp.1155~1164 (2009)
37. Smith KD, "Iron metabolism at the host pathogen interface : lipocalin 2 and the pathogen-associated iroA gene cluster", Int J Biochem Cell Biol, 39, pp.1776~1780 (2007)
38. Lloyd AL, "Uropathogenic Escherichia coli suppresses the host inflammatory response via pathogenicity island genes sisA and sisB", Infect Immun, 77, pp.5322~5333 (2009)
39. Jacobsen SM, "Proteus mirabilis biofilms and catheterassociated urinary tract infections", Virulence, 2, pp.460~465 (2011)
40. Pearson MM, "Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility", J Bacteriol, 190, pp.4027~4037 (2008)
41. Armbruster CE, "Merging mythology and morphology : the multifaceted lifestyle of Proteus mirabilis", Nat Rev Microbiol, 10, pp.743~754 (2012)
42. Cestari SE, "Molecular detection of HpmA and HlyA hemolysin of uropathogenic Proteus mirabilis", Curr Microbiol, 67, pp.703~707 (2013)
43. Alamuri P, "Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection", Infect Immun, 77, pp.632~641 (2009)
44. Alamuri P, "A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin", Mol Microbiol, 68, pp.997~1017 (2008)
45. Rather PN, "Swarmer cell differentiation in Proteus mirabilis", Environ Microbiol, 7, pp.1065~1073 (2005)
46. Himpsl SD, "Proteobactin and a yersiniabactin-related siderophore mediate iron acquisition in Proteus mirabilis", Mol Microbiol, 78, pp.138~157 (2010)
47. Lima A, "An iron-regulated outer-membrane protein of Proteus mirabilis is a haem receptor that plays an important role in urinary tract infection and in in vivo growth", J Med Microbiol, 56, pp.1600~1607 (2007)
48. Nielubowicz GR, "Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection", Infect Immun, 78, pp.2823~2833 (2010)
49. Belas R, "Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides", Infect Immun, 72, pp.5159~5167 (2004)
50. Stickler DJ, "Clinical complications of urinary catheters caused by crystalline biofilms : something needs to be done", J Intern Med, 276, pp.120~129 (2014)
51. Wu XR, "Uroplakins in urothelial biology, function, and disease", Kidney Int, 75, pp.1153~1165 (2009)
52. Ulett GC, "Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection", Curr Opin Microbiol, 16, pp.100~107 (2013)
53. Raffi HS, "Tamm-horsfall protein protects against urinary tract infection by proteus mirabilis", J Urol, 181, pp.2332~2338 (2009)
54. Duell BL, "Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection", J Immunol, 188, pp.781~792 (2012)
55. Sivick KE, "The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection", J Immunol, 184, pp.2065~2075 (2010)
56. Duell BL, "Recent insights into microbial triggers of interleukin-10 production in the host and the impact on infectious disease pathogenesis", FEMS Immunol Med Microbiol, 64, pp.295~313 (2012)
57. 최재영, "Clinical Significance of Toll-Like Receptor and Toll-Like Receptor Blocker", Urogenital Tract Infection, 11(1), pp.1~6 (2016), 대한요로생식기감염학회
58. LaRue H, "Toll-like receptors in urothelial cells--targets for cancer immunotherapy", Nat Rev Urol, 10, pp.537~545 (2013)
59. Thumbikat P, "Antigen-specific responses accelerate bacterial clearance in the bladder", J Immunol, 176, pp.3080~3086 (2006)
60. Taha Neto KA, "Oral vaccine(OM-89)in the recurrent urinary tract infection prophylaxis : a realistic systematic review with meta-analysis", Actas Urol Esp, 40, pp.203~208 (2016)
61. Spaulding CN, "Adhesive pili in UTI pathogenesis and drug development", Pathogens, 5, pp.E30~ (2016)
62. McLellan LK, "Urinary tract infection : pathogenesis and outlook", Trends Mol Med, 22, pp.946~957 (2016)
63. Huttner A, "Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection : a randomised, single-blind, placebo-controlled phase 1b trial", Lancet Infect Dis, 17, pp.528~537 (2017)
64. Mike LA, "Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection", Proc Natl Acad Sci U S A, 113, pp.13468~13473 (2016)
65. Flores-Mireles AL, "EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice", Sci Transl Med, 6, pp.254ra127~ (2014)
66. Kosikowska P, "Urease inhibitors as potential drugs for gastric and urinary tract infections : a patent review", Expert Opin Ther Pat, 21, pp.945~957 (2011)
67. Nielubowicz GR, "Outer membrane antigens of the uropathogen Proteus mirabilis recognized by the humoral response during experimental murine urinary tract infection", Infect Immun, 76, pp.4222~4231 (2008)

관련 논문AI추천